
Feds order avian influenza vaccine to protect individuals most at risk
The Public Health Agency of Canada (PHAC) is taking proactive measures to protect the health of Canadian citizens by securing a supply of a human vaccine against avian influenza.
While the current risk to the public remains low, individuals with higher-level exposure to infected animals are at increased risk.
Canada reported its first domestically acquired human case of avian influenza A (H5N1) on Nov. 9, 2024. To date, there has been no evidence of sustained person-to-person spread of the virus in any of the cases identified globally. However, avian influenza has the potential to cause serious illness in people.
PHAC will provide vaccines to provinces and territories based on a risk-based approach, with 60 per cent of available doses going to provinces and territories and 40 per cent kept in a federal stockpile for national preparedness.